N (%) | Mean ± SD | Median (Range) | |
---|---|---|---|
Age | 57.62 ± 12.9 | 60 (30-83) | |
<60 years | 12 (46.2) | ||
≥60 years | 14 (53.8) | ||
Menopause | |||
Premenopausal | 8 (30.8) | ||
Postmenopausal | 18 (69.2) | ||
Tumor type | |||
Inflammatory | 7 (26.9) | ||
Non-inflammatory | 19 (73.1) | ||
Tumor size | |||
T3 | 1 (3.8) | ||
T4a-T4b | 18 (69.2) | ||
T4c-T4d | 7 (27.0) | ||
Nodes | |||
N0 | 18 (69.2) | ||
N1-N2 | 8 (30.8) | ||
Metastasis | |||
M0 | 24 (92.3) | ||
M1 | 2 (7.7) | ||
Bra size | 100 ± 10.6 | 100 (80-120) | |
<100 | 9 (34.6) | ||
≥100 | 17 (65.4) | ||
Systemic treatment | |||
Chemotherapy | 4 (15.4) | ||
Hormonal therapy | 5 (19.2) | ||
Chemotherapy-hormonal therapy | 17 (65.4) | ||
Received dose (Gy) | 78.48 ± 5.7 | 81.60 (64.8-81.6) | |
<81.6 | 7 (26.9) | ||
≥81.6 | 19 (73.1) | ||
Maximum dose (Gy) | 87.36 ± 8.8 | 89.76 (62.8-101.7) | |
<89.8 | 15 (57.7) | ||
≥89.8 | 11 (42.3) |